Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
4immune Therapeutics logo — company profile

4immune Therapeutics

Founded 2021 1 employees Health Care, Health and Wellness

General Information

Company Name 4immune Therapeutics
Founded Year 2021
Employees 1
Industries Health Care, Health and Wellness
Social

Get notified when 4immune Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About 4immune Therapeutics

4immune Therapeutics has developed the first CAR T therapy to target and destroy the autoreactive T cells responsible for specific autoimmune disorders. Our multi-component CAR system with its novel adaptor molecule (CAL) bridges autologous or allogeneic CAR T cells to the offending autoreactive T cells to kill the cells and stop the disease in its tracks. Our first therapeutic targets early-stage type 1 diabetes, presently an incurable disease. There are many excellent therapies that successfully tamper down symptoms or prolong onset of the disease and have enhanced the quality of life for many patients. Others are achieving therapeutic value with beta cells transplants for late-stage patients. Our mission is to eradicate the disease-causing cells early in the process before too much pancreatic tissue damage has ensued and conquer autoimmune disorders for life. 4immune Therapeutics was founded in 2021. This innovative startup is revolutionizing the treatment of autoimmune disorders by addressing the root cause of the conditions. With its pioneering approach, the company has great potential to make a significant impact in the healthcare industry. As the company continues to advance its novel therapies, it presents promising investment opportunities for venture capitalists looking to support groundbreaking advancements in medical science.

No funding data available for 4immune Therapeutics yet.

Get notified when 4immune Therapeutics raises funding

4immune Therapeutics Alternatives & Competitors

4immune Therapeutics vs
Equillium, Inc.
Equillium, Inc. United States

Resetting Balance, Restoring Health

38 employees
4immune Therapeutics vs
Cimeio Therapeutics
Cimeio Therapeutics United States

Reinventing cell therapy through our leadership in the emerging field of epitope shielding

Series A
16 employees
4immune Therapeutics vs
Greywolf Therapeutics
Greywolf Therapeutics United Kingdom

We are advancing novel antigen modulation technology that controls T cells to guide the immune syste...

Series B
49 employees
Biotechnology, Health Care

FAQ About 4immune Therapeutics

4immune Therapeutics has developed the first CAR T therapy to target and destroy the autoreactive T cells responsible for specific autoimmune disorders. Our multi-component CAR system with its novel adaptor molecule (CAL) bridges autologous or allogeneic CAR T cells to the offending autoreactive T c...
4immune Therapeutics was founded in 2021.
4immune Therapeutics operates in the following industries: Health Care, Health and Wellness.
4immune Therapeutics has approximately 1 employees.
Top alternatives and competitors to 4immune Therapeutics include Equillium, Inc., Cimeio Therapeutics, Greywolf Therapeutics, Landos Biopharma, Inc., Nuvig Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
4immune Therapeutics and Equillium, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors 4immune Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy